Steve Silver analyst ARGUS

Currently out of the existing stock ratings of Steve Silver, 2 are a BUY (100%).

Steve Silver

Work Performance Price Targets & Ratings Chart

Analyst Steve Silver, currently employed at ARGUS,

Steve Silver’s has documented 4 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on DXCM, DexCom at 07-Nov-2025.

Wall Street Analyst Steve Silver

Analyst best performing recommendations are on DXCM (DEXCOM).
DXCM DexCom

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Jun-2025

$87

$15.46 (21.61%)

$80

11 days ago
(16-Jul-2026)

0/5 (0%)

$9.02 (11.57%)

Buy Since 29-Oct-2021

$90

$18.46 (25.80%)

$85

12 days ago
(15-Jul-2026)

2/7 (28.57%)

$17.27 (23.75%)

102

Buy Since 18-Nov-2019

$88

$17.86 (25.46%)

$75

1 months 12 days ago
(15-Jun-2026)

22/35 (62.86%)

$13.78 (18.57%)

138

Buy Since 11-Feb-2022

$95

$24.86 (35.44%)

$75

1 months 17 days ago
(10-Jun-2026)

5/9 (55.56%)

$20.23 (27.06%)

192

Buy Since 20-Oct-2025

$90

$19.86 (28.31%)

$85

1 months 22 days ago
(05-Jun-2026)

5/7 (71.43%)

$17.14 (23.52%)

134

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Steve Silver?

On 2025

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?